None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male or female patients aged 40 to 79 years. Patients with moderate or greater lumbar spinal stenosis (Schizas grade B or higher) involving a single lumbar segment between L1 and S1, who are candidates for lumbar interbody fusion surgery. Patients who have not responded to at least 3 months of conservative treatment, or who present with progressive neurological symptoms despite conservative treatment. Patients without communication difficulties that would interfere with the conduct and completion of the clinical trial. Patients willing to comply with the treatment and procedures of the study and to visit the hospital for all follow-up evaluations. Patients who have voluntarily signed a written informed consent form after receiving an explanation of the purpose, methods, and potential benefits of the clinical trial.
Exclusion criteria
Exclusion criteria: Patients requiring surgery for two or more lumbar segments. Patients with a history of lumbar fusion surgery. Patients with congenital lumbar spinal stenosis. Patients with radiologically confirmed grade 3 facet joint degeneration (Weishaupt grading system). Patients with sequestrated lumbar disc herniation. Patients with active local or systemic infection. Patients unable to undergo magnetic resonance imaging (MRI). Uncooperative patients or those with mental disorders making continued postoperative treatment difficult. Patients with preoperative lower limb muscle weakness (Manual Muscle Test grade = 3).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oswestry Disability Index | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale;EuroQol 5-Dimensions;Dubousset Functional Test;Self-Paced Walking Test;radiologic finding | — |
Countries
Korea, Republic of
Contacts
Seoul National University Hospital